Bitcoin Mining M&A Heats Up After Vertex’s $10 Billion Biotech Buyout
The post Bitcoin Mining M&A Heats Up After Vertex’s $10 Billion Biotech Buyout appeared on BitcoinEthereumNews.com. Crypto News Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for $10 billion in cash on Monday, July 6, sending the smaller drugmaker’s stock to a fresh all-time high as shares nearly doubled in a single session. Vertex will pay $85 per share, roughly twice Crinetics’ closing price the day before the announcement. The premium underscores how aggressively large-cap acquirers are chasing late-stage assets, a dynamic now spilling from biotech into digital-asset infrastructure. Our reading of the tape shows the deal instantly reset how the market values Crinetics, with the stock detaching from its own fundamentals and gravitating toward the agreed takeout price rather than its standalone growth outlook. What Vertex is actually buying is Palsonify, a once-daily pill for acromegaly — a rare disorder driven by excess growth hormone that patients previously mana